既往腹主动脉瘤修复术后破裂的临床表现、手术管理与长期结局
单中心回顾性研究分析2000至2020年40例既往腹主动脉瘤修复术后晚期主动脉破裂(LAR)患者,比较腔内修复(EVAR,组I,25例)与开放修复(OR,组II,15例)的结局。两组30天死亡率(8% vs 13%,P=.3)和并发症(32% vs 60%,P=.1)无显著差异,组I失血量更少(660 vs 3000 mL,P<.001)且需透析更少(0% vs 33%,P<.001);总体1、3、5年生存率分别为76%、52%、41%。
要点
- LAR更常见于研究后期(2010年后32例),可能由EVAR普及驱动。
- 既往EVAR后LAR发生时间短于既往OR后(6±4 vs 12±4年,P=.003)。
- 组I失血量660 mL少于组II 3000 mL(P<.001),需透析0%低于33%(P<.001)。
核心结论
- LAR在临床实践中更常见,可能由EVAR频率驱动;多数LAR包括既往OR后均可通过腔内技术挽救,并发症和死亡率更低。
研究设计与样本
- 单中心回顾性数据库分析2000至2020年因LAR治疗的患者,比较EVAR(组I)与OR(组II)结局。
主要发现
- 390例肾下主动脉破裂中40例(10%)为既往主动脉修复后LAR,34例男性,年龄78±8岁。
- LAR前EVAR 30例、前OR 10例;2010年后32例;初次EVAR后LAR 17例(42%)发生在再干预后。
- LAR治疗EVAR 25例(63%,组I)、OR 15例(37%,组II);组I中开窗修复7例(28%)。
- 组I失血量660 mL少于组II 3000 mL(P<.001),需透析0%低于33%(P<.001)。
- 30天死亡率组I 8% vs 组II 13%(P=.3),并发症32% vs 60%(P=.1),两组无显著差异;中位随访21个月(IQR 6-45),总体1、3、5年生存率76%、52%、41%。
临床怎么用
- 作者认为多数LAR包括既往OR后可通过腔内技术挽救,并发症和死亡率更低。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of the present study was to evaluate the presentation trends, intervention, and survival of patients who had been treated for late abdominal aortic aneurysm rupture (LAR) after open repair (OR) or endovascular aortic aneurysm repair (EVAR). METHODS: We reviewed the clinical data from a single-center, retrospective database for patients treated for LAR from 2000 to 2020. The end points were the 30-day mortality, major postoperative complication, and survival. The outcomes between LAR managed with EVAR (group I) vs OR were compared (group II). RESULTS: Of 390 patients with infrarenal aortic rupture, 40 (10%) had experienced aortic rupture after prior aortic repair and comprised the LAR cohort (34 men; age 78 ± 8 years). LAR had occurred before EVAR in 30 and before OR in 10 patients. LAR was more common in the second half of the study with 32 patients after 2010. LAR after prior OR was secondary to ruptured para-anastomotic pseudoaneurysms. After initial EVAR, LAR had occurred despite reintervention in 17 patients (42%). The time to LAR was shorter after prior EVAR than after OR (6 ± 4 vs 12 ± 4 years, respectively; P = .003). Treatment for LAR was EVAR for 25 patients (63%; group I) and OR for 15 (37%, group II). LAR after initial OR was managed with endovascular salvage for 8 of 10 patients. Endovascular management was more frequent in the latter half of the study period. In group I, fenestrated repair had been used for seven patients (28%). Salvage for the remaining cases was feasible with EVAR, aortic cuffs, or limb extensions. The incidence of free rupture, time to treatment, 30-day mortality (8% vs 13%; P = .3), complications (32% vs 60%; P = .1), and disposition were similar between the two groups. Those in group I had had less blood loss (660 vs 3000 mL; P < .001) and less need for dialysis (0% vs 33%; P < .001) than those in group II. The median follow-up was 21 months (interquartile range, 6-45 months). The overall 1-, 3-, and 5-year survival was 76%, 52%, and 41%, respectively, and was similar between groups (28 vs 22 months; P = .48). Late mortality was not related to the aorta. CONCLUSIONS: LAR after abdominal aortic aneurysm repair has been encountered more frequently in clinical practice, likely driven by the frequency of EVAR. However, most LARs, including those after previous OR, can now be salvaged with endovascular techniques with lower morbidity and mortality.
引用
- Sen I, Kanzafarova I, Yonkus J, et al. Clinical presentation, operative management, and long-term outcomes of rupture after previous abdominal aortic aneurysm repair. J Vasc Surg. 2022. PMID: 36272507. doi:10.1016/j.jvs.2022.08.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。